Evidence map›Paper›PMID 40655199›Full record

ArticleFood & nutrition research2025

A thermogenic botanical composition containing

Amulya Chadalavada, Yean Kyoung Koo, SukJin Kim, Sudipta Veeramachaneni, Guru Ramanathan, Amulya Yalamanchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food & nutrition research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Combination ofPreventive nutrition and food science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amulya ChadalavadaDepartment of General Medicine, Aditya Multi Speciality Hospital, Guntur, India.
Yean Kyoung KooDepartment of R&I Center, COSMAXBIO, Seongnam, Republic of Korea.
SukJin KimDepartment of R&I Center, COSMAXBIO, Seongnam, Republic of Korea.
Sudipta VeeramachaneniSV Scientific, One PPG Place, Suite 3300, Pittsburgh, PA, USA.
Guru RamanathanPharmacology-Based Clinical Trials Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Amulya YalamanchiDepartment of General Medicine, Yalamanchi Hospitals and Research Centre, Vijayawada, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: CL19183, or Theolim™, is a novel, proprietary combination of standardized extracts of Methods: The present study recruited 120 overweight male and female subjects (25-55 years) [body mass index (BMI) of 25-29.9 kg/m Results: Post-trial, CL19183 supplementation resulted in significant reductions in BW (4.25 ± 1.35 vs. 0.96 ± 1.18 kg; Conclusion: CL19183 supplementation was well-tolerated and led to significant BW reduction and improvements in BC over 16 weeks.

Indexed as

body compositionglucagon-like peptide-1resting metabolic rateTheolim™thermogenic botanical combination

Identifiers

PMID40655199
PMCPMC12255159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.